Back to Search
Start Over
Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study
- Source :
- The Lancet Infectious Diseases. 17:400-410
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
-
Abstract
- Summary Background Polymyxin antibiotics are used as last-resort therapies to treat infections caused by multidrug-resistant Gram-negative bacteria. The plasmid-mediated colistin resistance determinant MCR-1 has been identified in Enterobacteriaceae in China. We did this study to investigate the prevalence of the mcr-1 gene in clinical isolates from patients with bloodstream infections in China. Methods Clinical isolates of Escherichia coli and Klebsiella pneumoniae were collected from patients with bloodstream infections at 28 hospitals in China, then screened for colistin resistance by broth microdilution and for the presence of the mcr-1 gene by PCR amplification. We subjected mcr -1-positive isolates to genotyping, susceptibility testing, and clinical data analysis. We established the genetic location of mcr-1 with Southern blot hybridisation, and we analysed plasmids containing mcr-1 with filter mating, electroporation, and DNA sequencing. Findings 2066 isolates, consisting of 1495 E coli isolates and 571 K pneumoniae isolates were collected. Of the 1495 E coli isolates, 20 (1%) were mcr-1 -positive, whereas we detected only one ( mcr -1-positive isolate among the 571 K pneumoniae isolates. All mcr -1-positive E coli and K pneumoniae isolates were resistant to colistin, with minimum inhibitory concentrations values in the range of 4–32 mg/L, except for one E coli isolate that had a minimum inhibitory concentration less than or equal to 0·06 mg/L. All 21 mcr -1-positive isolates were susceptible to tigecycline and 20 isolates (95%) were susceptible to the carbapenem and β-lactamase inhibitor combination piperacillin and tazobactam. One mcr -1-positive E coli isolate also produced NDM-5, which confers resistance to beta-lactam antibiotics. The 21 mcr -1-positive isolates were clonally diverse and carried mcr-1 on two types of plasmids, a 33 kb IncX4 plasmid and a 61 kb Inc12 plasmid. The 30 day mortality of the patients with bloodstream infections caused by mcr -1-positive isolates was zero. Interpretation mcr -1-positive isolates from bloodstream infections were rare, sporadic, and remained susceptible to many antimicrobial agents. E coli , rather than K pneumoniae , was the main host of the mcr-1 gene. Further studies are needed to clarify the clinical impact of this novel resistance gene. Funding National Natural Science Foundation of China.
- Subjects :
- 0301 basic medicine
China
Carbapenem
Genotype
Klebsiella pneumoniae
medicine.drug_class
030106 microbiology
Antibiotics
Microbial Sensitivity Tests
Tigecycline
Microbiology
03 medical and health sciences
Minimum inhibitory concentration
Bacterial Proteins
Drug Resistance, Bacterial
Escherichia coli
Prevalence
medicine
Humans
Longitudinal Studies
Escherichia coli Infections
biology
Broth microdilution
biology.organism_classification
Virology
Anti-Bacterial Agents
Klebsiella Infections
Infectious Diseases
Colistin
MCR-1
hormones, hormone substitutes, and hormone antagonists
Plasmids
medicine.drug
Subjects
Details
- ISSN :
- 14733099
- Volume :
- 17
- Database :
- OpenAIRE
- Journal :
- The Lancet Infectious Diseases
- Accession number :
- edsair.doi.dedup.....d6d0c1382b6422a3d203ecf5e3756afe